Latest Commercial Scale Up News

5E Advanced Materials has released a robust Preliminary Feasibility Study for its Fort Cady Project in California, highlighting a 39.5-year mine life and strong economics with a pre-tax NPV7 of US$724.8 million and a 19.2% IRR.

5E Advanced Materials has released a comprehensive Preliminary Feasibility Study for its Fort Cady boron project in California, outlining robust economics and a 39.5-year mine life. The study highlights strong market fundamentals amid tightening global boric acid supply.

Papyrus Australia appoints Daniel Schmidt as CEO to lead its transition from R&D to commercial operations, alongside a strategic restructure to support growth.

Stellar Resources has confirmed that large-scale X-Ray Transmission ore sorting trials at its Heemskirk Tin Project significantly increase tin head grade while reducing processing costs. The promising results are now shaping the project's Prefeasibility Study.

Firebird Metals has received a significant Expression of Interest from Taza Metal Technologies to purchase up to five of its energy-efficient kilns, potentially generating over US$10 million in revenue. This marks a key step in Firebird’s international commercial expansion and highlights its leadership in sustainable manganese processing technology.

Nanollose Limited has completed a successful pilot manufacturing run blending its Nullarbor-20 fibre with wool, raised $1.05 million through an entitlement issue, and appointed Andrew Moullin as CEO to drive its commercialisation strategy.

Adherium Limited reports a robust 30% increase in US remote patient monitoring users and closes a $4.5 million capital raise, positioning itself for accelerated growth under new leadership.

Papyrus Australia has made significant strides in Q2 2025, launching its Rapid Prototyping and R&D Facility and successfully trialling new banana fibre-based products, while deepening academic partnerships.

International Graphite Limited (ASX, IG6) has signed a cooperation agreement to develop a 3,000 t/y expandable graphite facility in Germany, advancing its global footprint alongside progress at its Collie micronising plant and Springdale project, supported by potential US Department of Defense funding.

Renascor Resources has achieved provisional development approval for its commercial-scale Battery Anode Material manufacturing facility, alongside significant progress in graphite production and exploration activities. The company maintains a robust cash position of A$105 million as it advances its vertically integrated graphite project.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.